Literature DB >> 1990844

No severe bottleneck during human evolution: evidence from two apolipoprotein C-II deficiency alleles.

W J Xiong1, W H Li, I Posner, T Yamamura, A Yamamoto, A M Gotto, L Chan.   

Abstract

The DNA sequences of a Japanese and a Venezuelan apolipoprotein (apo) C-II deficiency allele, of a normal Japanese apo C-II gene, and of a chimpanzee apo C-II gene were amplified by PCR, and their nucleotide sequences were determined on multiple clones of the PCR products. The normal Japanese sequence is identical to--and the chimpanzee sequence differs by only three nucleotides from--a previously published normal Caucasian sequence. In contrast, the two human mutant sequences each differ from the normal apo C-II gene sequence by several nucleotides, including deletions. The data suggest that both mutant alleles arose greater than 500,000 years ago. It is shown that a defective allele can persist in a population for only a short time if a bottleneck occurs. Therefore, the antiquity of the two alleles suggests no severe bottleneck during human evolution. Moreover, the fact that one allele is from Japan and the other is from a Venezuelan Caucasian family is more consistent with the multiregional evolution model of modern human origins than with the complete replacement or "out of Africa" model.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1990844      PMCID: PMC1683008     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Probability of identical monomorphism in related species.

Authors:  M Nei; W H Li
Journal:  Genet Res       Date:  1975-08       Impact factor: 1.588

2.  Total number of individuals affected by a single deleterious mutation in a finite population.

Authors:  W H Li; M Nei
Journal:  Am J Hum Genet       Date:  1972-11       Impact factor: 11.025

3.  Immunological time scale for hominid evolution.

Authors:  V M Sarich; A C Wilson
Journal:  Science       Date:  1967-12-01       Impact factor: 47.728

4.  Population size and protein variation in man.

Authors:  J Haigh; J M Smith
Journal:  Genet Res       Date:  1972-02       Impact factor: 1.588

5.  Apolipoprotein CII in type I hyperlipoproteinemia. A study in three cases.

Authors:  M L Kashyap; L S Srivastava; R C Tsang; M R Taskinen; B A Hynd; G Perisutti; D W Brady; C J Glueck; C A Ahumada; J A McCarthy; R A Sosa; T O Reeds
Journal:  J Lab Clin Med       Date:  1980-02

6.  An initiation codon mutation in the apoC-II gene (apoC-II Paris) of a patient with a deficiency of apolipoprotein C-II.

Authors:  S S Fojo; J L de Gennes; J Chapman; C Parrott; P Lohse; S S Kwan; J Truffert; H B Brewer
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

7.  Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency.

Authors:  T Yamamura; H Sudo; K Ishikawa; A Yamamoto
Journal:  Atherosclerosis       Date:  1979-09       Impact factor: 5.162

8.  Polymorphism in mitochondrial DNA of humans as revealed by restriction endonuclease analysis.

Authors:  W M Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.

Authors:  M L Kashyap; L S Srivastava; C Y Chen; C G Perisutti; M Campbell; R F Lutmer; C J Glueck
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  7 in total

1.  Lactase haplotype diversity in the Old World.

Authors:  E J Hollox; M Poulter; M Zvarik; V Ferak; A Krause; T Jenkins; N Saha; A I Kozlov; D M Swallow
Journal:  Am J Hum Genet       Date:  2000-11-28       Impact factor: 11.025

2.  Microevolution of the Chibcha-speaking peoples of lower Central America: rare genes in an Amerindian complex.

Authors:  E A Thompson; J V Neel; P E Smouse; R Barrantes
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

3.  Cloning and sequencing of bovine apolipoprotein E complementary DNA and molecular evolution of apolipoproteins E, C-I, and C-II.

Authors:  Y W Yang; L Chan; W H Li
Journal:  J Mol Evol       Date:  1991-06       Impact factor: 2.395

4.  Low nucleotide diversity in man.

Authors:  W H Li; L A Sadler
Journal:  Genetics       Date:  1991-10       Impact factor: 4.562

Review 5.  The pathophysiology of intestinal lipoprotein production.

Authors:  Antonina Giammanco; Angelo B Cefalù; Davide Noto; Maurizio R Averna
Journal:  Front Physiol       Date:  2015-03-20       Impact factor: 4.566

6.  Cloning and characterization of an apolipoprotein C2 promoter in the mouse central nervous system.

Authors:  Zhaoyang Li; Bing Du; Shengyang Li; Xiangchuan Lv; Shenglai Zhou; Yang Yu; Wei Wang; Zhihong Zheng
Journal:  Neural Regen Res       Date:  2013-01-15       Impact factor: 5.135

7.  A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis.

Authors:  Jingjing Jiang; Yuhui Wang; Yan Ling; Abudurexiti Kayoumu; George Liu; Xin Gao
Journal:  Lipids Health Dis       Date:  2016-01-16       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.